title: Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.
abstract: Targeting nanoparticles (NPs) loaded with drugs and probes to precise locations in the body may improve the treatment and detection of many diseases. Generally, to achieve targeting, affinity ligands are introduced on the surface of NPs that can bind to molecules present on the cell of interest. Optimization of ligand density is a critical parameter in controlling NP binding to target cells, and a higher ligand density is not always the most effective. In this study, we investigated how NP avidity affects targeting to the pulmonary vasculature, using NPs targeted to ICAM-1. This cell adhesion molecule is expressed by quiescent endothelium at modest levels and is upregulated in a variety of pathological settings. NP avidity was controlled by ligand density, with the expected result that higher avidity NPs demonstrated greater pulmonary uptake than lower avidity NPs in both naive and pathological mice. However, in comparison with high-avidity NPs, low-avidity NPs exhibited several-fold higher selectivity of targeting to pathological endothelium. This finding was translated into a PET imaging platform that was more effective in detecting pulmonary vascular inflammation using low-avidity NPs. Furthermore, computational modeling revealed that elevated expression of ICAM-1 on the endothelium is critical for multivalent anchoring of NPs with low avidity, while high-avidity NPs anchor effectively to both quiescent and activated endothelium. These results provide a paradigm that can be used to optimize NP targeting by manipulating ligand density and may find biomedical utility for increasing detection of pathological vasculature.
authors: Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
authors: Blaine J
authors: BJ
authors: Zern
authors: Ann-Marie
authors: AM
authors: Chacko
authors: Jin
authors: J
authors: Liu
authors: Colin F
authors: CF
authors: Greineder
authors: Eric R
authors: ER
authors: Blankemeyer
authors: Ravi
authors: R
authors: Radhakrishnan
authors: Vladimir
authors: V
authors: Muzykantov
mesh_terms: D000818:Animals; D055910:Antibodies, Immobilized; D000915:Antibody Affinity; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D005260:Female; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D053758:Nanoparticles; D036103:Nanotechnology; D011014:Pneumonia / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology; D049268:Positron-Emission Tomography
chemical_list: D055910:Antibodies, Immobilized; D018799:Intercellular Adhesion Molecule-1
references: Curr Opin Colloid Interface Sci. 2011 Jun;16(3):215-227
references: 21709761
references: ACS Nano. 2011 Mar 22;5(3):1693-702
references: 21375342
references: J Control Release. 2013 Feb 10;165(3):216-25
references: 23142578
references: Am J Physiol. 1998 Oct;275(4):L806-17
references: 9755114
references: Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1292-303
references: 9714137
references: ACS Nano. 2012 Feb 28;6(2):1463-72
references: 22260171
references: Atherosclerosis. 2003 Oct;170(2):191-203
references: 14612198
references: Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16530-5
references: 20823256
references: Cancer Lett. 2006 Jul 18;238(2):188-96
references: 16111806
references: J Am Chem Soc. 2009 Jul 8;131(26):9311-20
references: 19527027
references: Bioconjug Chem. 2007 Sep-Oct;18(5):1424-33
references: 17760416
references: J Control Release. 2003 Sep 19;92(1-2):49-67
references: 14499185
references: J Phys Chem C Nanomater Interfaces. 2007 Nov 1;111(43):15848-15856
references: 19081797
references: ACS Nano. 2012 Jun 26;6(6):5648-58
references: 22671719
references: Biomaterials. 2012 Jul;33(21):5406-13
references: 22560201
references: Hypertension. 1997 Feb;29(2):683-9
references: 9040457
references: IEEE Trans Med Imaging. 2005 Jul;24(7):844-52
references: 16011313
references: Nanomedicine (Lond). 2011 Sep;6(7):1257-72
references: 21929460
references: J Control Release. 2012 Nov 28;164(1):95-102
references: 22974689
references: Biomaterials. 2011 May;32(13):3487-98
references: 21306773
references: J Am Chem Soc. 2010 Aug 18;132(32):11306-13
references: 20698697
references: Mol Pharm. 2010 Oct 4;7(5):1569-75
references: 20666515
references: J Clin Pathol. 1983 May;36(5):539-45
references: 6302135
references: Adv Mater. 2012 Jul 24;24(28):3803-22, 3710
references: 22674563
references: ACS Nano. 2011 Feb 22;5(2):738-47
references: 21275414
references: Blood. 2005 Jan 15;105(2):650-8
references: 15367437
references: Sci Transl Med. 2011 May 25;3(84):84ra44
references: 21613623
references: Curr Pharm Des. 2005;11(18):2383-401
references: 16022673
references: Biophys J. 2002 Oct;83(4):2270-9
references: 12324444
references: Nat Nanotechnol. 2008 Mar;3(3):145-50
references: 18654486
references: J Pharmacol Exp Ther. 2006 Jun;317(3):1161-9
references: 16505161
references: Biorheology. 2009;46(4):323-41
references: 19721193
references: Science. 2012 Nov 16;338(6109):903-10
references: 23161990
references: Blood. 2003 May 15;101(10):3977-84
references: 12531816
references: IUBMB Life. 2011 Aug;63(8):640-7
references: 21721099
references: Langmuir. 2008 Aug 19;24(16):8821-32
references: 18630976
references: ACS Nano. 2011 Sep 27;5(9):6991-9
references: 21838300
references: Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):750-7
references: 21252070
references: Biomacromolecules. 2010 Jul 12;11(7):1785-95
references: 20536119
references: Q J Nucl Med. 2003 Dec;47(4):279-91
references: 14973420
references: Cancer. 2002 Mar 1;94(5):1593-611
references: 11920518
references: ACS Nano. 2011 Nov 22;5(11):8967-73
references: 22003968
references: Anal Biochem. 2005 Mar 15;338(2):284-93
references: 15745749
references: Nat Nanotechnol. 2012 Jun 03;7(6):389-93
references: 22659608
references: J Pharm Sci. 2011 Mar;100(3):1045-56
references: 20922813
references: Proc Natl Acad Sci U S A. 1996 May 28;93(11):5213-8
references: 8643555
references: Biophys J. 1984 Jun;45(6):1051-64
references: 6743742
references: Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6105-10
references: 19342490
references: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91
references: 18272481
references: Biophys J. 2011 Jul 20;101(2):319-26
references: 21767483
references: Adv Drug Deliv Rev. 2004 Apr 19;56(6):763-78
references: 15063588
references: J Control Release. 2011 Feb 28;150(1):37-44
references: 21047540
references: Curr Nanosci. 2011 Oct 1;7(5):727-735
references: 22116782
references: Nanomedicine. 2013 Feb;9(2):194-201
references: 22687896
references: J Nucl Med. 2008 Jan;49(1):103-11
references: 18077519
references: Curr Drug Metab. 2012 Jan;13(1):70-81
references: 22292809
references: ACS Nano. 2012 Jan 24;6(1):696-704
references: 22214176
references: Atherosclerosis. 2011 Aug;217(2):364-70
references: 21601207
references: FASEB J. 2013 Jan;27(1):255-64
references: 23047896
references: Nanomedicine. 2010 Apr;6(2):334-43
references: 19800989
references: Nanomedicine. 2011 Apr;7(2):201-9
references: 20816874
references: J Pharmacol Exp Ther. 2008 May;325(2):400-8
references: 18287213